作者: Michael Graupe , John O. Link
DOI:
关键词:
摘要: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S therefore useful treating diseases mediated by these proteases. pharmaceutical compositions comprising processes for preparing them.